Cargando…
A prognostic and immunotherapy effectiveness model for pancreatic adenocarcinoma based on cuproptosis-related lncRNAs signature
Pancreatic adenocarcinoma (PAAD) results in one of the deadliest solid tumors with discouraging clinical outcomes. Growing evidence suggests that long non-coding RNAs (lncRNAs) play a crucial role in altering the growth, prognosis, migration, and invasion of pancreatic cancer cells. Cuproptosis is a...
Autores principales: | Zhang, Ning, Yu, Xuehua, Sun, Hui, Zhao, Yunhong, Wu, Jing, Liu, Gaifang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589590/ https://www.ncbi.nlm.nih.gov/pubmed/37861553 http://dx.doi.org/10.1097/MD.0000000000035167 |
Ejemplares similares
-
A novel prognostic signature for lung adenocarcinoma based on cuproptosis-related lncRNAs: A Review
por: Di, Huang, et al.
Publicado: (2022) -
Establishment of a prognostic signature for lung adenocarcinoma using cuproptosis-related lncRNAs
por: Yalimaimaiti, Saiyidan, et al.
Publicado: (2023) -
Construction of a pyroptosis-related lncRNAs signature for predicting prognosis and immunotherapy response in glioma
por: Huang, Qianrong, et al.
Publicado: (2023) -
Cuproptosis-related prognostic signatures predict the prognosis and immunotherapy in HCC patients
por: Peng, Hong, et al.
Publicado: (2023) -
Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response
por: Li, Chong, et al.
Publicado: (2023)